Viewing Study NCT00609804


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2025-12-26 @ 9:23 PM
Study NCT ID: NCT00609804
Status: COMPLETED
Last Update Posted: 2016-04-08
First Post: 2008-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Sponsor: SCRI Development Innovations, LLC
Organization: